Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...
With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Deputy Prime Minister and Minister of Health and Population Khaled Abdel Ghaffar said Egypt has played a crucial role in ...
Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...
20hon MSN
Q4 2024 Management View CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, ...
21h
GlobalData on MSNBambusa Therapeutics doses first volunteers in Phase I bispecific AD trialThe Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
Multibagger stock Vantage Knowledge Academy Limited hits upper circuit after setting record date for 2:1 bonus shares. The ...
He said that investing in an index fund is somewhat like buying quantitative funds where algorithms are used to pick stocks.
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 11,666.74 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results